Rates of AKI with ACE Inhibitor and Angiotensin-Receptor Blocker Use

被引：0
|
作者：
Tabet, Michael I. [1 ]
Sarrazin, Mary Vaughan [1 ]
Jalal, Diana I. [1 ]
Misurac, Jason [1 ]
Griffin, Benjamin R. [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024yqy6y6x4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO042
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety
    Flaten, Hania K.
    Monte, Andrew A.
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (04) : 471 - 482
  • [22] Attenuation of heart failure due to coronary stenosis by ACE inhibitor and angiotensin receptor blocker
    Sato, H
    Yaoita, H
    Maehara, K
    Maruyama, Y
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (01): : H359 - H368
  • [23] The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety
    Hania K. Flaten
    Andrew A. Monte
    Cardiovascular Drugs and Therapy, 2017, 31 : 471 - 482
  • [24] Choosing the right angiotensin-receptor blocker for patients with diabetes: still controversial
    Cooper, Mark E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (12) : 1023 - 1024
  • [25] A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER
    Goh, T. H.
    Tan, S. C.
    Fook-Chong, S. M. C.
    Wong, K. S.
    Chan, C. M.
    NEPHROLOGY, 2005, 10 : A139 - A139
  • [26] Use of an ACE inhibitor or angiotensin receptor blocker is a major risk factor for dehydration requiring readmission in the setting of a new ileostomy
    Gregory Charak
    Benjamin A. Kuritzkes
    Ahmed Al-Mazrou
    Kunal Suradkar
    Neda Valizadeh
    Steven A. Lee-Kong
    Daniel L. Feingold
    Emmanouil P. Pappou
    International Journal of Colorectal Disease, 2018, 33 : 311 - 316
  • [27] Use of an ACE inhibitor or angiotensin receptor blocker is a major risk factor for dehydration requiring readmission in the setting of a new ileostomy
    Charak, Gregory
    Kuritzkes, Benjamin A.
    Al-Mazrou, Ahmed
    Suradkar, Kunal
    Valizadeh, Neda
    Lee-Kong, Steven A.
    Feingold, Daniel L.
    Pappou, Emmanouil P.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (03) : 311 - 316
  • [28] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    Cohn, JN
    Tognoni, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23): : 1667 - 1675
  • [29] Pharmacokinetics of angiotensin-receptor blocker in cyclodextrin nanoparticle eye drops in rabbits
    Kallab, Martin
    Schutzenberger, Kornelia
    Hommer, Nikolaus
    Schafer, Bhavapriya Jasmin
    Tan, Aimin
    Jansook, Phatsawee
    Stefansson, Einar
    Garhofer, Gerhard
    ACTA OPHTHALMOLOGICA, 2019, 97
  • [30] Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels
    Komine, N
    Khang, S
    Wead, LM
    Blantz, RC
    Gabbai, FB
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (01) : 159 - 164
12345